First quarter, 2021
- Net sales amounted to MSEK 129.5 (38.0), which corresponded to an increase of 241% (55) compared to the corresponding period previous year, of which 62% (25) was organic growth.
- Operating profit before depreciation (EBITDA) amounted to MSEK -34.9 (-5.7), corresponding to a margin of -26.9% (-14.9). The operating profit during the quarter was affected by acquisition costs totaling MSEK 20.5.
-
Profit/loss for the period amounted to MSEK -47.8 (-33.5), which generated earnings per share after dilution of
SEK -0.90 (-0.80). The result was positively affected by the market valuation of the company's short-term investments of MSEK 4.4 (-22.7). - The gross margin amounted to 77.3% (74.8), mainly due to higher revenue per product, improved product mix and increased share of sales in services and consumables.
- Rolling twelve-month net sales from consumables amounted to MSEK 46.2 (19.2), an increase of 140%. The share of total product sales was 12.9%, a decrease of 0.2 percentage points (13.1% in the comparison period).
- During the quarter, the Finnish company Ginolis, specializing in advanced diagnostics automation and advanced robotics solutions, was acquired for MSEK 648.8. In addition, the American company MatTek, a global leader in in-vitro technology and alternative drug testing models for pharmaceuticals and cosmetic products, was acquired for MSEK 610.
- During March, the offering of senior unsecured convertible bonds convertible to Class B share and a class B share issue to a total amount of MDSEK 3 were completed.
"
"The first quarter resulted in continued high organic growth and a strengthened gross margin mainly due to higher average revenue per product, an improved product mix and an increased share of sales of services and consumables. The Group was burdened by increased costs during the quarter which was attributable to acquisition related costs, increased investments in personnel, systems, and innovative product development. The quarter has historically been the Group's weakest and Industrial Solutions had a negative impact on earnings due to a lower delivery rate compared with the significant positive impact on earnings that the segment had in the previous quarter (Q5, 2019/2020). The variation was due to the order- and the delivery situation during the year, where the segment historically has made its entire profit in the second half of the year. However, it should be emphasized that Industrial Solutions ended the quarter with a historically large order backlog.", says Erik Gatenholm, CEO
Digital Capital Markets Day,
The presentation for the CMD will be available on the company's website on 13.45 (CEST). The presentations will also be recorded and available post the CMD at the company's website. For program and more information about the CMD please visit https://www.cellink.com/investors/cellink-digital-capital-market-day/.
Date:
Registration: https://www.cellink.com/investors/cellink-digital-capital-market-day/. The CMD will take place on the digital platform GoToWebinar.
Annex: Interim report January-
This information is such that
For further information, please contact:
Erik Gatenholm, CEO Phone ( Phone (US): +1 (650) 515 5566 Email: eg@cellink.com | Phone ( Phone (US): +1 (857) 332 2138 Email: gd@cellink.com |
About
Founded in 2016,
https://news.cision.com/cellink-ab/r/interim-report-january-march-2021--high-organic-growth--strengthened-gross-margin--and-strategic-acq,c3345576
https://mb.cision.com/Main/14960/3345576/1416359.pdf
https://mb.cision.com/Public/14960/3345576/9ce411753d6a1f22.pdf
(c) 2021 Cision. All rights reserved., source